Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $12

Barclays analyst Steve Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $15 to $12.
byBenzinga Newsdesk
July 20, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Barclays analyst Steve Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $15 to $12.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Foot Locker Shares Are Moving

By Henry Khederian
December 22, 11:27 AM
Foot Locker Inc (NYSE: FL) shares are trading lower by 5.4% to $30.58 during Friday's session. Shares of footwear and athletic apparel stocks are trading lower in sympathy with Nike, which fell after reporting mixed second-quarter results, lowering its outlook and announcing

FL